Paracetamol: New Vistas of an Old Drug

Alfio Bertolini, Anna Ferrari, Alessandra Ottani, Simona Guerzoni, Raffaella Tacchi, Sheila Leone
{"title":"Paracetamol: New Vistas of an Old Drug","authors":"Alfio Bertolini,&nbsp;Anna Ferrari,&nbsp;Alessandra Ottani,&nbsp;Simona Guerzoni,&nbsp;Raffaella Tacchi,&nbsp;Sheila Leone","doi":"10.1111/j.1527-3458.2006.00250.x","DOIUrl":null,"url":null,"abstract":"<p>Paracetamol (acetaminophen) is one of the most popular and widely used drugs for the treatment of pain and fever. It occupies a unique position among analgesic drugs. Unlike NSAIDs it is almost unanimously considered to have no antiinflammatory activity and does not produce gastrointestinal damage or untoward cardiorenal effects. Unlike opiates it is almost ineffective in intense pain and has no depressant effect on respiration. Although paracetamol has been used clinically for more than a century, its mode of action has been a mystery until about one year ago, when two independent groups (Zygmunt and colleagues and Bertolini and colleagues) produced experimental data unequivocally demonstrating that the analgesic effect of paracetamol is due to the indirect activation of cannabinoid CB<sub>1</sub> receptors. In brain and spinal cord, paracetamol, following deacetylation to its primary amine (p-aminophenol), is conjugated with arachidonic acid to form N-arachidonoylphenolamine, a compound already known (AM404) as an endogenous cannabinoid. The involved enzyme is fatty acid amide hydrolase. N-arachidonoylphenolamine is an agonist at TRPV1 receptors and an inhibitor of cellular anandamide uptake, which leads to increased levels of endogenous cannabinoids; moreover, it inhibits cyclooxygenases in the brain, albeit at concentrations that are probably not attainable with analgesic doses of paracetamol. CB<sub>1</sub> receptor antagonist, at a dose level that completely prevents the analgesic activity of a selective CB<sub>1</sub> receptor agonist, completely prevents the analgesic activity of paracetamol. Thus, paracetamol acts as a pro-drug, the active one being a cannabinoid. These findings finally explain the mechanism of action of paracetamol and the peculiarity of its effects, including the behavioral ones. Curiously, just when the first CB<sub>1</sub> agonists are being introduced for pain treatment, it comes out that an indirect cannabino-mimetic had been extensively used (and sometimes overused) for more than a century.</p>","PeriodicalId":94307,"journal":{"name":"CNS drug reviews","volume":"12 3-4","pages":"250-275"},"PeriodicalIF":0.0000,"publicationDate":"2007-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1527-3458.2006.00250.x","citationCount":"582","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS drug reviews","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2006.00250.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 582

Abstract

Paracetamol (acetaminophen) is one of the most popular and widely used drugs for the treatment of pain and fever. It occupies a unique position among analgesic drugs. Unlike NSAIDs it is almost unanimously considered to have no antiinflammatory activity and does not produce gastrointestinal damage or untoward cardiorenal effects. Unlike opiates it is almost ineffective in intense pain and has no depressant effect on respiration. Although paracetamol has been used clinically for more than a century, its mode of action has been a mystery until about one year ago, when two independent groups (Zygmunt and colleagues and Bertolini and colleagues) produced experimental data unequivocally demonstrating that the analgesic effect of paracetamol is due to the indirect activation of cannabinoid CB1 receptors. In brain and spinal cord, paracetamol, following deacetylation to its primary amine (p-aminophenol), is conjugated with arachidonic acid to form N-arachidonoylphenolamine, a compound already known (AM404) as an endogenous cannabinoid. The involved enzyme is fatty acid amide hydrolase. N-arachidonoylphenolamine is an agonist at TRPV1 receptors and an inhibitor of cellular anandamide uptake, which leads to increased levels of endogenous cannabinoids; moreover, it inhibits cyclooxygenases in the brain, albeit at concentrations that are probably not attainable with analgesic doses of paracetamol. CB1 receptor antagonist, at a dose level that completely prevents the analgesic activity of a selective CB1 receptor agonist, completely prevents the analgesic activity of paracetamol. Thus, paracetamol acts as a pro-drug, the active one being a cannabinoid. These findings finally explain the mechanism of action of paracetamol and the peculiarity of its effects, including the behavioral ones. Curiously, just when the first CB1 agonists are being introduced for pain treatment, it comes out that an indirect cannabino-mimetic had been extensively used (and sometimes overused) for more than a century.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
扑热息痛:一种老药的新前景
扑热息痛(对乙酰氨基酚)是最受欢迎和广泛使用的治疗疼痛和发烧的药物之一。它在镇痛药中占有独特的地位。与非甾体抗炎药不同,它几乎被一致认为没有抗炎活性,不会产生胃肠道损伤或不利的心肾作用。与阿片类药物不同,它对剧烈疼痛几乎无效,对呼吸也没有抑制作用。尽管扑热息痛已经在临床上使用了一个多世纪,但它的作用方式一直是个谜,直到大约一年前,两个独立的研究小组(Zygmunt及其同事和Bertolini及其同事)得出的实验数据明确表明,扑热息痛的镇痛作用是由于大麻素CB1受体的间接激活。在脑和脊髓中,扑热息痛在脱乙酰化成其伯胺(对氨基酚)后,与花生四烯酸结合形成n -花生四烯醇基酚胺,这是一种已知的内源性大麻素化合物(AM404)。所涉及的酶是脂肪酸酰胺水解酶。n -花生四烯醇酚胺是TRPV1受体的激动剂和细胞anandamide摄取的抑制剂,这导致内源性大麻素水平增加;此外,它还能抑制大脑中的环氧合酶,尽管其浓度可能是止痛剂量的扑热息痛无法达到的。CB1受体拮抗剂,在完全阻止选择性CB1受体激动剂的镇痛活性的剂量水平上,完全阻止扑热息痛的镇痛活性。因此,扑热息痛是一种前药,其活性成分是大麻素。这些发现最终解释了扑热息痛的作用机制及其作用的特殊性,包括行为作用。奇怪的是,就在第一批CB1激动剂被引入疼痛治疗的时候,一种间接的大麻模拟物已经被广泛使用(有时被过度使用)了一个多世纪。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
ERRATUM Cortagine: Behavioral and Autonomic Function of the Selective CRF Receptor Subtype 1 Agonist Guanfacine and Guanfacine Extended Release: Treatment for ADHD and Related Disorders Pharmacology of the β-Carboline FG-7142, a Partial Inverse Agonist at the Benzodiazepine Allosteric Site of the GABAA Receptor: Neurochemical, Neurophysiological, and Behavioral Effects AUTHOR INDEX FOR VOLUME 13
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1